ROCHENEL PIERRE: Open Payments
NPI 1730847914 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 29 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $440 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $438 |
| Janssen Pharmaceuticals, Inc | 4 | $140 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, Auvelity, SPRAVATO, LYBALVI, ERZOFRI EXTENDED-RELEASE.
Industry payments across FL — which companies pay providers there.
